Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
CHE LHCG AMED GTIV Small Blend Munis Stores Cars 
United States GSPC USD ...  |  Screen Global Equities


Processing
Processing. Please wait...

Amedisys Return On Asset

 
 Companies |  Insiders  | Dashboard  
     

Return On Asset breakdown for Amedisys

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Amedisys

Return on Asset

=

Net Income

Total Assets

X

100

=
3.32 %
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Compare Amedisys to competition

Amedisys Return On Asset Assessment

Based on latest financial disclosure Amedisys Inc has Return On Asset of 3.32%. This is 119.87% lower than that of Healthcare sector, and 42.86% lower than that of Home Health Care industry, The Return On Asset for all stocks is 153.21% lower than the firm.

Filter other Stocks by Return On Asset

Select Return On Asset Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  

Return On Asset Comparison

Amedisys is rated fifth in return on asset category among related companies.
Follow Amedisys Return On Asset with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Amedisys to your reader
 
    
AMED United States Nasdaq
Amedisys Inc
Benchmark S&P 500
Currency: USD - US Dollar
Traded on NASDAQ
    
    

Other Amedisys Fundamentals

Return On Equity(20.51) %
Return On Asset3.32 %
Profit Margin(6.01) %
Operating Margin2.90 %
Current Valuation421.94 M
Shares Outstanding31.46 M
Shares Owned by Insiders1.94 %
Shares Owned by Institutions79.20 %
Number of Shares Shorted3.67 M
Price to Earning20.24 times
Price to Book0.75 times
Price to Sales0.24 times
Revenue1.44 B
EBITDA81.61 M
Net Income(86.1 M)
Cash and Equivalents7.02 M
Cash per Share0.22 times
Total Debt78.76 M
Debt to Equity0.17 times
Current Ratio0.90 times
Book Value Per Share14.67 times
Cash Flow from Operations90.98 M
Short Ratio12.00 times
One Year High15.95
One Year Low8.81
Earnings Per Share(2.86) times
Price to Earnings To Growth1.72 times
Number of Employees15.2 K
Beta1.23
Market Capitalization350.19 M
Z Score2.4
Probability Of Bankruptcy35.60 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium